Turn Biotechnologies Co-Founder to Present at Prestigious ARDD Meeting in Copenhagen

Turn Biotechnologies co-founder Vittorio Sebastiano will share company data during a presentation on the potential of epigenetic reprogramming to increase human longevity during this week’s 10th Aging Research and Drug Discovery Meeting (ARDD), the world’s largest longevity forum. Epigenetic reprogramming…